2oye: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:2oye.jpg|left|200px]]
{{Seed}}
[[Image:2oye.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2oye|  PDB=2oye  |  SCENE=  }}  
{{STRUCTURE_2oye|  PDB=2oye  |  SCENE=  }}  


'''Indomethacin-(R)-alpha-ethyl-ethanolamide bound to Cyclooxygenase-1'''
===Indomethacin-(R)-alpha-ethyl-ethanolamide bound to Cyclooxygenase-1===




==Overview==
<!--
The modification of the nonselective nonsteroidal anti-inflammatory drug, indomethacin, by amidation presents a promising strategy for designing novel cyclooxygenase (COX)-2-selective inhibitors. A series of alpha-substituted indomethacin ethanolamides, which exist as R/S-enantiomeric pairs, provides a means to study the impact of stereochemistry on COX inhibition. Comparative studies revealed that the R- and S-enantiomers of the alpha-substituted analogs inhibit COX-2 with almost equal efficacy, whereas COX-1 is selectively inhibited by the S-enantiomers. Mutagenesis studies have not been able to identify residues that manifest the enantioselectivity in COX-1. In an effort to understand the structural impact of chirality on COX-1 selectivity, the crystal structures of ovine COX-1 in complexes with an enantiomeric pair of these indomethacin ethanolamides were determined at resolutions between 2.75 and 2.85 A. These structures reveal unique, enantiomer-selective interactions within the COX-1 side pocket region that stabilize drug binding and account for the chiral selectivity observed with the (S)-alpha-substituted indomethacin ethanolamides. Kinetic analysis of binding demonstrates that both inhibitors bind quickly utilizing a two-step mechanism. However, the second binding step is readily reversible for the R-enantiomer, whereas for the S-enantiomer, it is not. These studies establish for the first time the structural and kinetic basis of high affinity binding of a neutral inhibitor to COX-1 and demonstrate that the side pocket of COX-1, previously thought to be sterically inaccessible, can serve as a binding pocket for inhibitor association.
The line below this paragraph, {{ABSTRACT_PUBMED_17656360}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 17656360 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_17656360}}


==About this Structure==
==About this Structure==
Line 31: Line 35:
[[Category: Oxidoreductase]]
[[Category: Oxidoreductase]]
[[Category: Pgh]]
[[Category: Pgh]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 11:55:57 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 01:40:33 2008''

Revision as of 01:40, 28 July 2008

File:2oye.png

Template:STRUCTURE 2oye

Indomethacin-(R)-alpha-ethyl-ethanolamide bound to Cyclooxygenase-1Indomethacin-(R)-alpha-ethyl-ethanolamide bound to Cyclooxygenase-1

Template:ABSTRACT PUBMED 17656360

About this StructureAbout this Structure

2OYE is a Single protein structure of sequence from Ovis aries. Full crystallographic information is available from OCA.

ReferenceReference

Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides., Harman CA, Turman MV, Kozak KR, Marnett LJ, Smith WL, Garavito RM, J Biol Chem. 2007 Sep 21;282(38):28096-105. Epub 2007 Jul 26. PMID:17656360

Page seeded by OCA on Mon Jul 28 01:40:33 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA